Literature DB >> 33840039

Crossed cerebellar diaschisis: risk factors and prognostic value in focal cortical dysplasia by 18F-FDG PET/CT.

Guoguang Zhao1, Jie Lu2,3,4, Yaqin Hou5, Kun Guo5, Xiaotong Fan6, Kun Shang5, Jingjuan Wang5, Zhenming Wang7, Yongzhi Shan6.   

Abstract

PURPOSE: Crossed cerebellar diaschisis (CCD) has been widely studied in hemispheric stroke but is less characterized in epilepsy. In this study, we used 18F-FDG PET/CT to investigate the risk factors for CCD and its prognostic value for intractable epilepsy caused by focal cortical dysplasia (FCD).
METHODS: One hundred medically intractable epilepsy patients pathologically diagnosed with FCD postoperatively were included and classified into two groups: CCD+ and CCD-. PET/CT images were analyzed qualitatively by visual assessment and semi-quantitatively using the absolute asymmetry index (|AI|). Clinical factors, including age, sex, body mass index (BMI), age at seizure onset, epilepsy duration, seizure type, seizure frequency, electroencephalography (EEG) and brain magnetic resonance imaging (MRI), were retrospectively assessed from medical records. Follow-up outcomes were evaluated according to the Engel classification at 3, 6, 12, 24 and 36 months postoperatively.
RESULTS: Of the 100 patients, 77 (77.0%) were classified as CCD-, and 23 (23.0%) were classified as CCD + . CCD+ patients had a higher number of lobes involved on PET (3.61 ± 2.16 vs 2.26 ± 1.01, P < 0.001) than CCD- patients. CCD- patients showed more negative MRI results than CCD + patients (P = 0.02). At 12 months postoperatively, 70.7% (29/41) of CCD- patients and 30.8% (4/13) of CCD + patients presented a favourable prognosis (P = 0.02). Significant differences in the average |AI| values in the posterior frontal and anterior temporal lobes were found between CCD+ and CCD- patients (P < 0.05).
CONCLUSION: The number of lobes involved on PET, structural anomalies on MRI, the |AI| values in the posterior frontal and anterior temporal lobes may be predisposing factors for CCD. CCD occurrence may help predict the prognosis of FCD patients at 12 months postoperatively.

Entities:  

Keywords:  18F-FDG PET; Crossed cerebellar diaschisis; Focal cortical dysplasia; Medically intractable epilepsy

Year:  2021        PMID: 33840039     DOI: 10.1007/s12149-021-01613-8

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  5 in total

1.  ILAE Commission Report. Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery.

Authors:  H G Wieser; W T Blume; D Fish; E Goldensohn; A Hufnagel; D King; M R Sperling; H Lüders; T A Pedley
Journal:  Epilepsia       Date:  2001-02       Impact factor: 5.864

2.  Increased contralateral cerebellar uptake of technetium-99m-HMPAO on ictal brain SPECT.

Authors:  J H Won; J D Lee; T S Chung; C Y Park; B I Lee
Journal:  J Nucl Med       Date:  1996-03       Impact factor: 10.057

3.  Technetium-99m HM-PAO brain SPECT in epileptic patients before and during unilateral hemispheric anesthesia (Wada test): report of three cases.

Authors:  H J Biersack; D Linke; F Brassel; K Reichmann; M Kurthen; H F Durwen; B M Reuter; J Wappenschmidt; H Stefan
Journal:  J Nucl Med       Date:  1987-11       Impact factor: 10.057

4.  Crossed-cerebellar diaschisis in cerebral infarction: technetium-99m-HMPAO SPECT and MRI.

Authors:  S E Kim; C W Choi; B W Yoon; J K Chung; J H Roh; M C Lee; C S Koh
Journal:  J Nucl Med       Date:  1997-01       Impact factor: 10.057

Review 5.  The role of radionuclide imaging in epilepsy, Part 1: Sporadic temporal and extratemporal lobe epilepsy.

Authors:  Ajay Kumar; Harry T Chugani
Journal:  J Nucl Med       Date:  2013-08-22       Impact factor: 10.057

  5 in total
  1 in total

1.  Crossed cerebellar diaschisis-related supratentorial hemodynamic and metabolic status measured by PET/MR in assessing postoperative prognosis in chronic ischemic cerebrovascular disease patients with bypass surgery.

Authors:  Bixiao Cui; Yi Shan; Tianhao Zhang; Yan Ma; Bin Yang; Hongwei Yang; Liqun Jiao; Baoci Shan; Jie Lu
Journal:  Ann Nucl Med       Date:  2022-07-05       Impact factor: 2.258

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.